___________________________

David M. Harlan, MD

William and Doris Krupp Professor of Medicine

Co-Director, UMass Chan Medical School Diabetes Center of Excellence

Director, JDRF Center of Excellence in New England

Dr. Harlan is an internationally acclaimed diabetes physician-scientist at UMass Chan Medical School and UMass Memorial Medical Center in Worcester, Massachusetts

For nearly 40 years Dr. Harlan has conducted basic and clinical research exploring the pathophysiology underlying diabetes. He has served as Co-Director of the UMass Chan Medical School’s Diabetes Center of Excellence since 2010 and spent ten years as Chief of the Department of Medicine Diabetes Division at UMass Memorial Health. During that time, clinic volume more than tripled, and novel communication tools were developed to better engage patients in their own care. Prior to his arrival in Worcester, Dr. Harlan served as Chief of the National Institutes of Health (NIH) Intramural Research Program’s Diabetes Branch (NIDDK).

His accomplishments and diabetes expertise are internationally acclaimed as a physician-scientist. He has been invited to speak worldwide including Australia, Saudi Arabia, India, France, Spain, England, Sweden, Brazil and Canada.

Dr. Harlan served on the NIDDK Diseases Advisory Council and Medical Science Review Committee of the Juvenile Diabetes Foundation International, been a respected member of the Biological Response Modifiers Advisory Committee for the FDA, Chaired the American Diabetes Association Scientific Sessions Planning Committee, and was an ad hoc member of the Howard Hughes Medical Institute Scientific Review Board.

Honors & awards received throughout his career include the Frank Brown Berry Prize for Federal Medicine, Legion of Merit from the United States Navy, Peter Forsham Award for Academic Excellence from the Society of Uniformed Endocrinologists, U.S. PHS Physician Researcher of the Year Award, Children with Diabetes Foundation Friend for Life Award and Massachusetts Medical Law Report Rx for Excellence Award for “Leader in Quality,” and the 2022 Rachmiel Levine Award from City of Hope.

Barry Meisenberg, M.D.

Hematology and Oncology, Hematology, Oncology

Barry Meisenberg M.D. has been the Chair of the Department of Medicine at Anne Arundel Medical Center (AAMC) since 2018 and the medical director of the DeCesaris Cancer Institute and Service Line from 2008-2019. He has provided leadership for the multi-disciplinary programs of the institute and emerging technologies to offer patients the best in cancer treatment and care. Under his leadership, the Institute has expanded to include implementation of Novalis Tx™ radiosurgery, the Cancer Survivorship Program, the cancer rehabilitation program, the relocation and expansion of the Outpatient Infusion Center, expansion of the AAMC Breast Center, the creation of the Rapid Access Lung Program, a lung cancer screening program, enhanced focus on financial navigation and counseling among other clinical programs. He is certified by the American Board of Internal Medicine in Hematology, Internal Medicine and Medical Oncology.

Dr. Meisenberg is also Chair of Quality Improvement and Health Systems Research for the medical system. In this role he directs the Center for Health Care Improvement with an overall goal to study, define and implement care and process innovation. A key element of the center is the organizing of data and analytics which enables clinicians to refine care with the goal of improved quality at a lower cost. Collaborating with physician, nursing and administrative leadership, Dr. Meisenberg steers and develops a long-range strategy for quality and process improvement. As director of the Research Institute, Dr. Meisenberg oversees all aspects of clinical research at the institution including tissue transfer, clinical trials and health systems research.

A nationally recognized oncologist and hematology expert, Dr. Meisenberg came to AAMC from the University of Maryland School of Medicine, where he headed the Division of Hematology/Oncology at the Marlene and Stewart Greenebaum Cancer Center and was Deputy Director for Clinical Affairs of the Cancer Center. Previously, he held clinical and academic positions at Duke University. He also is a visiting professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He received his medical degree from Albany Medical College in New York, and completed his residency in internal medicine and a fellowship in Hematology/Oncology at the Naval Hospital in San Diego.

Widely published in oncology and research journals, he also has received numerous awards and distinctions, including the Mildred Mindell Foundation Award for Outstanding Physician and the Greenebaum Cancer Center’s Directors Award for Enhancements in Patient Safety (2006).

VADM (Ret.) Matthew Nathan, M.D.

Dr. Matthew  L. Nathan joined the Humanetics Board of Directors in 2020 and was elected as Chairman in 2022. Dr. Nathan served as the 37th Surgeon General of the Navy and Chief of the Navy’s Bureau of Medicine and Surgery, where he oversaw 64,000 personnel with a budget approaching $9 Billion. Dr. Nathan also served as Commander, Walter Reed National Military Medical Center and Navy Medicine, where he managed the largest medical integration and construction project in the Department of Defense history. Dr. Nathan is board certified and holds Fellow status in the American College of Physicians and the American College of Healthcare Executives. He currently serves as Senior Vice President Physician Practices and Enterprise Leader for the Campus at the WakeMed Health System in Raleigh, North Carolina.